Literature DB >> 11342188

The role of beta-tubulin isotypes in resistance to antimitotic drugs.

C A Burkhart1, M Kavallaris, S Band Horwitz.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11342188     DOI： 10.1016/s0304-419x(00)00022-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  52 in total

Review 1.  Mechanisms of Taxol resistance related to microtubules.

Authors:  George A Orr; Pascal Verdier-Pinard; Hayley McDaid; Susan Band Horwitz
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

2.  A ubiquitous beta-tubulin disrupts microtubule assembly and inhibits cell proliferation.

Authors:  Rajat Bhattacharya; Fernando Cabral
Journal:  Mol Biol Cell       Date:  2004-04-30       Impact factor: 4.138

3.  Modulation of the anti-cancer efficacy of microtubule-targeting agents by cellular growth conditions.

Authors:  Jay F Dorsey; Melissa L Dowling; Mijin Kim; Ranh Voong; Lawrence J Solin; Gary D Kao
Journal:  Cancer Biol Ther       Date:  2010-05-15       Impact factor: 4.742

4.  Molecular basis for class V beta-tubulin effects on microtubule assembly and paclitaxel resistance.

Authors:  Rajat Bhattacharya; Fernando Cabral
Journal:  J Biol Chem       Date:  2009-03-12       Impact factor: 5.157

5.  Docetaxel-carboxymethylcellulose nanoparticles display enhanced anti-tumor activity in murine models of castration-resistant prostate cancer.

Authors:  Bryan Hoang; Mark J Ernsting; Mami Murakami; Elijus Undzys; Shyh-Dar Li
Journal:  Int J Pharm       Date:  2014-05-20       Impact factor: 5.875

6.  Class III beta-tubulin expression predicts prostate tumor aggressiveness and patient response to docetaxel-based chemotherapy.

Authors:  Guillaume Ploussard; Stéphane Terry; Pascale Maillé; Yves Allory; Nanor Sirab; Laurence Kheuang; Pascale Soyeux; Nathalie Nicolaiew; Estelle Coppolani; Bernard Paule; Laurent Salomon; Stéphane Culine; Ralph Buttyan; Francis Vacherot; Alexandre de la Taille
Journal:  Cancer Res       Date:  2010-11-02       Impact factor: 12.701

Review 7.  Microtubule targeting agents: from biophysics to proteomics.

Authors:  D Calligaris; P Verdier-Pinard; F Devred; C Villard; D Braguer; Daniel Lafitte
Journal:  Cell Mol Life Sci       Date:  2010-01-28       Impact factor: 9.261

Review 8.  Microtubules and resistance to tubulin-binding agents.

Authors:  Maria Kavallaris
Journal:  Nat Rev Cancer       Date:  2010-02-11       Impact factor: 60.716

Review 9.  [Biomarkers - the way towards individualized chemotherapy in non-small cell lung cancer (NSCLC)].

Authors:  Sabine Danzinger; Martin Filipits
Journal:  Wien Med Wochenschr       Date:  2007

10.  Neurogenesis and neurite outgrowth in the spinal cord of chicken embryos and in primary cultures of spinal neurons following knockdown of Class III beta tubulin with antisense morpholinos.

Authors:  Richard P Tucker; Ha Tran; Qizhi Gong
Journal:  Protoplasma       Date:  2008-09-30       Impact factor: 3.356
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.